Copyright
©The Author(s) 2023.
World J Clin Cases. Feb 16, 2023; 11(5): 1040-1048
Published online Feb 16, 2023. doi: 10.12998/wjcc.v11.i5.1040
Published online Feb 16, 2023. doi: 10.12998/wjcc.v11.i5.1040
General information | Control group (n = 141) | Study group (n = 93) | χ2 | P | |
Sex | Male | 70 (49.65) | 56 (60.22) | 2.519 | 0.112 |
Female | 71 (50.35) | 37 (39.78) | |||
Age (years) | < 60 | 80 (56.74) | 36 (38.71) | 7.286 | 0.007 |
≥ 60 | 61 (43.26) | 57 (61.29) | |||
Smoking | Yes | 48 (34.04) | 39 (41.94) | 1.495 | 0.221 |
No | 93 (65.96) | 54 (58.06) | |||
Tumor type | lung cancer | 52 (36.88) | 69 (74.19) | 36.127 | < 0.001 |
Mammary cancer | 52 (36.88) | 21 (22.58) | |||
Esophageal cancer | 37 (26.24) | 3 (2.23) | |||
TNM stage | II | 43 (30.50) | 39 (41.94) | 5.065 | 0.079 |
III | 54 (38.30) | 36 (38.71) | |||
IV | 44 (31.20) | 18 (19.35) | |||
History of chemotherapy | Yes | 36 (25.53) | 57 (61.29) | 29.921 | < 0.001 |
No | 105 (74.47) | 36 (38.71) | |||
Operation | Yes | 47 (33.33) | 39 (41.94) | 1.784 | 0.182 |
No | 94 (66.67) | 54 (58.06) |
Group (n) | FEV1 (%) | DLCO (%) | FEV1/FVC (%) | PTV (mL) | MLD (Gy) | Total number of radiation fields | Vdose (%) | NTCP (%) |
Control group (n = 141) | 76.89 ± 6.25 | 71.97 ± 10.03 | 72.19 ± 7.44 | 28.26 ± 8.31 | 35.29 ± 6.57 | 7.07 ± 2.07 | 24.54 ± 10.33 | 42.45 ± 3.60 |
Study group (n = 93) | 70.26 ± 7.50 | 64.19 ± 9.71 | 64.45 ± 7.20 | 38.48 ± 8.27 | 40.71 ± 5.42 | 8.00 ± 1.71 | 36.06 ± 9.95 | 49.29 ± 4.72 |
t | 7.339 | 5.918 | 7.940 | 9.235 | 6.599 | 3.731 | 8.589 | 12.540 |
P | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 |
Factor | B | S.E. | Wald | P | OR | 95%CI |
Age | -2.232 | 0.842 | 7.028 | 0.008 | 0.11 | 0.02-0.48 |
Tumor type (Lung) | ||||||
Mammary | -3.038 | 0.938 | 8.313 | 0.001 | 0.05 | 0.01-0.26 |
Esophageal | -3.753 | 1.075 | 8.313 | < 0.001 | 0.02 | 0.00-0.16 |
History of chemotherapy | 3.108 | 0.854 | 13.259 | < 0.001 | 22.37 | 4.85-143.77 |
FEV1 | 0.292 | 0.096 | 9.199 | 0.002 | 1.34 | 1.13-1.65 |
DLCO | 0.410 | 0.093 | 19.226 | < 0.001 | 1.51 | 1.28-1.85 |
FEV1/FVC ratio | -0.329 | 0.119 | 7.656 | 0.006 | 0.72 | 0.59-0.90 |
PTV | 0.477 | 0.149 | 10.206 | 0.001 | 1.61 | 1.23-2.22 |
MLD | -0.217 | 0.118 | 3.377 | 0.066 | 0.80 | 0.65-1.03 |
Total number of radiation fields | -0.905 | 0.244 | 13.812 | < 0.001 | 0.40 | 0.23-0.62 |
Vdose | -0.127 | 0.086 | 2.189 | 0.139 | 0.88 | 0.74-1.04 |
NTCP | 1.206 | 0.211 | 32.636 | < 0.001 | 3.34 | 2.33-5.41 |
- Citation: Shi LL, Yang JH, Yao HF. Multiple regression analysis of risk factors related to radiation pneumonitis. World J Clin Cases 2023; 11(5): 1040-1048
- URL: https://www.wjgnet.com/2307-8960/full/v11/i5/1040.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i5.1040